Yale New Haven — New Haven, Connecticut

Yale New Haven is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Yale New Haven has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Peripheral Arterial Hemorrhage, Trauma, GI Bleed.

Sponsors: Medtronic Endovascular, CareDx, Penumbra Inc..

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Yale New Haven?

Yale New Haven has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Yale New Haven conducted?

Yale New Haven has 5 clinical trials on record, with 3 currently active. Their work covers Peripheral Arterial Hemorrhage, Trauma, GI Bleed.

Is Yale New Haven accredited by Crixeo Health?

Yes — Yale New Haven holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Yale New Haven?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.